Article
Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
The international journal of neuropsychopharmacology - 1 Nov 2013
Dobarro Marta, Gerenu Gorka, Ramírez María J
Abstract excerpt
The efficacy of antihypertensive agents in Alzheimer's disease (AD) is controversial. It has been tested here whether some antihypertensive drugs might influence AD through mechanisms independent of blood pressure-lowering activity. The effects of treatment with the antihypertensive propranolol on cognition and AD-related markers have been studied in the Tg2576 mouse model of AD. Propranolol, at a lower dose than...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
